Recent Price Action
On 8/13/24, Catalyst Biosciences Inc (NASDAQ: CBIO) stock declined by -2.5%, closing at $10.40. However, trading volume in this decline was exceptionally low at 46% of normal. Relative to the market the stock has been extremely weak over the last nine months but has risen 2.7% during the last week.
Current PriceTarget Research Rating
CBIO is expected to be a major Value Eraser reflecting capital returns that are forecasted to fall short of the cost of capital.
Catalyst Biosciences is currently unrated.
Rating Review
The stock is currently unrated.